BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Ocugen Provides Business Update with First Quarter 2026 Financial Results

  May 5, 2026

   · 

  14 min read
• Press Releases

  Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

  May 5, 2026

   · 

  6 min read
• Press Releases

  Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

  May 5, 2026

   · 

  8 min read
• Press Releases

  Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.

  May 5, 2026

   · 

  6 min read
• Press Releases

  Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

  May 5, 2026

   · 

  4 min read
• Press Releases

  IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026

  May 5, 2026

   · 

  4 min read
• Press Releases

  Clene Announces $7 Million Underwritten Offering of Common Stock

  May 5, 2026

   · 

  6 min read
• Press Releases

  CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

  May 5, 2026

   · 

  1 min read
• Press Releases

  Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

  May 5, 2026

   · 

  10 min read
• Press Releases

  Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline

  May 5, 2026

   · 

  11 min read